Emulate is developing Organs-on-Chips technology to understand human diseases. By emulating human biology, Emulate is using the power of Organs-on-Chips to generate in vitro models that recreate human biology with their Human Emulation System. Emulate’s technology is already in use by many researchers and companies including GlaxoSmithKline. Emulate has already had success in creating a Shigella infection model using a human Intestine-Chip and has developed a range of validated Organ-Chip models for brain, liver, kidney and lung. These human-relevant models will enable Emulate to study disease and to revolutionize preclinical drug discovery.

<p>Emulate is developing Organs-on-Chips technology to understand human diseases. By emulating human biology, Emulate is using the power of Organs-on-Chips to generate in vitro models that recreate human biology with their Human Emulation System. Emulate’s technology is already in use by many researchers and companies including GlaxoSmithKline.</p>
<p>Emulate has already had success in creating a Shigella infection model using a human Intestine-Chip and has developed a range of validated Organ-Chip models for brain, liver, kidney and lung. These human-relevant models will enable Emulate to study disease and to revolutionize preclinical drug discovery.</p>


Emulate

Founded: 2013
Location: Boston, MA
Employee range: 50 - 200
Funding: $82M E Sep 2021; $36M C Jun 2018; $17M B2 Oct 2016; $28M B1 Apr 2016; $12M Jul 2014

Senior Accountant

Emulate

Short description:

Drug notes:

Long description:

Jobs: